Putnam Investments LLC Halozyme Therapeutics, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 272,146 shares of HALO stock, worth $16.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

272,146

Previous 267,191 1.85%

Holding current value

$16.2 Million

Previous $10.2 Million 1.45%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $165,100 - $208,605	4,955 Added 1.85%	272,146 $10.1 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $991,128 - $1.2 Million	27,184 Added 11.33%	267,191 $10.2 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $1.38 Million - $1.77 Million	-45,656 Reduced 15.98%	240,007 $8.66 Million
Q1 2023 May 22, 2023	SELL	$32.86 - $55.7 $793,141 - $1.34 Million	-24,137 Reduced 7.79%	285,663 $10.9 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $25,197 - $37,387	-629 Reduced 0.2%	309,800 $17.6 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $110,465 - $148,453	-2,867 Reduced 0.92%	310,429 $12.3 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $82,431 - $106,598	2,207 Added 0.71%	313,296 $13.8 Million
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $283,893 - $364,612	-8,880 Reduced 2.78%	311,089 $12.4 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $331,373 - $424,370	10,414 Added 3.36%	319,969 $12.9 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $920,048 - $1.11 Million	23,916 Added 8.37%	309,555 $12.6 Million
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $5.06 Million - $6.59 Million	128,016 Added 81.22%	285,639 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $4.07 Million - $6.88 Million	157,623 New	157,623 $6.73 Million

Others Institutions Holding HALO

# of Institutions

526

Shares Held

123M

Call Options Held

208K

Put Options Held

77.1K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.3B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Halozyme Therapeutics, Inc. Transaction History